maytansine - CISMeF

Preferred Label : maytansine;

MeSH definition : An ansa macrolide isolated from the MAYTENUS genus of East African shrubs.;

MeSH synonym : Maitansine;

DeCS synonym : Maytansinoid DM4; Maytansinoid DM1; Ravtansine; Emtansine; Soravtansine; Mertansine;

Wikipedia automatic translation : Maytansinoid;

Related MeSH term : DM1, Maytansinoid; Mertansine; Emtansine; DM4, Maytansinoid; N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine; Soravtansine; Ravtansine; DMMO-Maytansine; DMMO Maytansine;

MeSH Related Number : 35846-53-8 (Maytansine);

Registry Number MeSH : 35846-53-8;

Wikipedia link : https://en.wikipedia.org/wiki/Maytansinoid;

Codes EINECS : 252-754-7;

Is substance : O;

UNII : 14083FR882;

InChIKey : WKPWGQKGSOKKOO-RSFHAFMBSA-N;

Details

Origin ID

D008453;

UMLS CUI

C0024975;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Ravtansine [NCIt concept]
- Soravtansine [NCIt concept]
CISMeF manual mappings
- maytansine [Substance BNPC]
Currated CISMeF NLP mapping
- Maytansine [NCIt concept]
Pharmacological action(s)
- antineoplastic agents, phytogenic [MeSH Descriptor]
- tubulin modulators [MeSH Descriptor]
Record concept(s)
- Maytansinoid DM1 [MeSH concept]
- Maytansinoid DM4 [MeSH concept]
- maytansine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 15-methoxyansamitocin P-3 [MeSH Supplementary Concept]
- 2 0-demethoxy-20-((4-azidobenzoyl)oxy)maytansinol-3-isobutyrate [MeSH Supplementary Concept]
- 20-demethoxy-20-(3-(((5-dimethylamino)naphthalen-1-yl)sulfonyl)amino)propylmaytansinol-3-isobutyrate [MeSH Supplementary Concept]
- AMG 595 [MeSH Supplementary Concept]
- AVE9633 [MeSH Supplementary Concept]
- EC131 conjugate [MeSH Supplementary Concept]
- LY3076226 [MeSH Supplementary Concept]
- MLN2704 antibody [MeSH Supplementary Concept]
- N(2')-deacetyl-N(2')-(3-mercapto-1-oxopropyl)maytansine [MeSH Supplementary Concept]
- N-desmethyl-4,5-desepoxymaytansinol [MeSH Supplementary Concept]
- N-methylmaysenine [MeSH Supplementary Concept]
- SIP(F8)-SS-DM1 [MeSH Supplementary Concept]
- anetumab ravtansine [MeSH Supplementary Concept]
- ansamitocins [MeSH Supplementary Concept]
- bivatuzumab mertansine [MeSH Supplementary Concept]
- cantuzumab mertansine [MeSH Supplementary Concept]
- coltuximab ravtansine [MeSH Supplementary Concept]
- colubrinol [MeSH Supplementary Concept]
- dechloroansamitocin P-3 [MeSH Supplementary Concept]
- indatuximab ravtansine [MeSH Supplementary Concept]
- lorvotuzumab mertansine [MeSH Supplementary Concept]
- maytanprine [MeSH Supplementary Concept]
- maytansinol [MeSH Supplementary Concept]
- mirvetuximab soravtansine [MeSH Supplementary Concept]
- normaytansine [MeSH Supplementary Concept]
- seco-proansamitocin [MeSH Supplementary Concept]
- trewiasine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Maytansine [NCIt concept]
- maytansine [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients